Markets:

Overview

News

Currencies

International

Treasuries

Virax Biolabs Group Limited - Ordinary Shares (NQ:VRAX)

0.2073 +0.0047 (+2.32%)

Streaming Delayed Price Updated: 3:06 PM EDT, Mar 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Virax Biolabs Group Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

Get insights into the top gainers and losers of Wednesday's after-hours session. ↗

February 18, 2026

Via Chartmill

Wondering what's happening in today's after-hours session? ↗

December 31, 2025

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

December 04, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

What's going on in today's pre-market session ↗

December 04, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

How Is The Market Feeling About Virax Biolabs Group? ↗

October 28, 2024

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

December 03, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

December 03, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.

Via Chartmill

Scienjoy (NASDAQ: SJ): Deep-Value, Cash-Rich Tech with Mixed-Reality Upside More Inside

December 03, 2025

Via AB Newswire

Topics Artificial Intelligence Economy

These stocks are the most active in today's session ↗

December 03, 2025

Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.

Via Chartmill

These stocks are moving in today's session ↗

December 03, 2025

Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Which stocks are gapping on Wednesday? ↗

December 03, 2025

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Get insights into the top gainers and losers of Wednesday's pre-market session. ↗

December 03, 2025

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 26, 2025

Via Benzinga

EXCLUSIVE: Virax Biolabs Inks Research Pact To Advance Long COVID Diagnostic Studies ↗

August 26, 2025

Virax Biolabs partners with Emory University to study its T cell diagnostic ViraxImmune for long COVID, aiming for FDA guidance and U.S. market entry.

Via Benzinga

What's Driving the Market Sentiment Around Virax Biolabs Group? ↗

June 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 14, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 11, 2025

Via Benzinga

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating ↗

March 31, 2025

Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.

Via Benzinga

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency ↗

February 25, 2025

Virax Biolabs supports HHS's focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research.

Via Benzinga

Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗

December 19, 2024

Via Benzinga

Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX

October 23, 2024

Via AB Newswire

Topics Intellectual Property

Nasdaq Down 2%; US Crude Stocks Increase ↗

October 23, 2024

Via Benzinga

Gold Moves Lower; AT&T Earnings Top Views ↗

October 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 23, 2024

Via Benzinga

Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss ↗

October 23, 2024

Via Benzinga

Topics Stocks

EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland ↗

October 23, 2024

Virax Biolabs partners with Europa Biosite to distribute ImmuneSelect for research use, focusing on T-cell immunity and post-viral syndromes, including Long COVID.

Via Benzinga

EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In August 2024 – Where Do Tesla, Nvidia, Apple, AMD Stock Rank? ↗

September 03, 2024

A look at the top 20 most-searched tickers on Benzinga Pro for the month of August.

Via Benzinga

Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results ↗

August 28, 2024

Via Benzinga

What's Going On With Virax Biolabs Stock Wednesday ↗

August 28, 2024

Virax Biolabs stock is trading higher on Wednesday after the company announced it entered into a distribution agreement with a supplier of RT-PCR Mpox detection kits.

Via Benzinga

Topics Supply Chain

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.